Metraipolis › archive › dc_ff5c50db30ff

Comparative Longitudinal Evaluation of Systemic Inflammatory Markers in Type 2 Diabetes Treated with Four Oral Antidiabetic Drug Classes — Europe PMC PMID:41598626

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41598626
DOI: 10.3390/jcm15020688
License (as archived): solo-consultazione
Archived: 2026-11-06T18:50:39.612Z
SHA-256 of the archived text: 106f37072d1b6f0b61dd9c24279f6f669cc8dde5eb57d700dd730aeb7e198657
Stable URL of this page: https://metraipolis.com/documento/dc_ff5c50db30ff

How to cite

Comparative Longitudinal Evaluation of Systemic Inflammatory Markers in Type 2 Diabetes Treated with Four Oral Antidiabetic Drug Classes — Europe PMC PMID:41598626 — Europe PMC (en), https://europepmc.org/article/MED/41598626 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff5c50db30ff (Metraipolis archive dc_ff5c50db30ff, sha256 106f37072d1b6f0b61dd9c24279f6f669cc8dde5eb57d700dd730aeb7e198657)

BibTeX

@misc{dcff5c50db30ff,
  title = {Comparative Longitudinal Evaluation of Systemic Inflammatory Markers in Type 2 Diabetes Treated with Four Oral Antidiabetic Drug Classes — Europe PMC PMID:41598626},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41598626},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff5c50db30ff; sha256 106f37072d1b6f0b61dd9c24279f6f669cc8dde5eb57d700dd730aeb7e198657},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41598626. Agents can read the archived copy with the MCP tool read_document.